Yuanming L. Qi
100 Kexue Avenue
Zhengzhou, 450001, China
Zhengzhou, 450001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Development of a lymph node-homing peptide vaccine targeting C-C chemokine receptor 7-positive dendritic cells with enhanced antitumor immunity.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: September 17, 2025
In Situ Engineering of Tumor Cells as Self-Sustaining cDC1 Programming Factories for Effective Cancer Immunotherapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 20, 2025
Screening and identification of HLA-A2-restricted neoepitopes for immunotherapy in endocrine therapy-resistant breast cancer.
Journal: Neoplasia (New York, N.Y.)
Published: April 10, 2025
Mitochondrial transplantation rescues Ca2+ homeostasis imbalance and myocardial hypertrophy in SLC25A3-related hypertrophic cardiomyopathy.
Journal: Cell reports
Published: May 13, 2024
Identification of a novel DEC-205 binding peptide to develop dendritic cell-targeting nanovaccine for cancer immunotherapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: April 22, 2024
Discovery of a novel small molecule as CD47/SIRPα and PD-1/PD-L1 dual inhibitor for cancer immunotherapy.
Journal: Cell communication and signaling : CCS
Published: August 21, 2023
Hemin blocks TIGIT/PVR interaction and induces ferroptosis to elicit synergistic effects of cancer immunotherapy.
Journal: Science China. Life sciences
Published: August 13, 2023
Comprehensive mapping of alternative polyadenylation site usage and its dynamics at single-cell resolution.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 01, 2022
Identification of natural product 3, 5-diiodotyrosine as APOBEC3B inhibitor to prevent somatic mutation accumulation and cancer progression.
Journal: Journal for immunotherapy of cancer
Published: October 10, 2022
Peptide vaccine from cancer-testis antigen ODF2 can potentiate the cytotoxic T lymphocyte infiltration through IL-15 in non-MSI-H colorectal cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: August 26, 2022
Identification of a novel GLUT1 inhibitor with in vitro and in vivo anti-tumor activity.
Journal: International journal of biological macromolecules
Published: April 04, 2022
Engineered Nanovaccine Targeting Clec9a+ Dendritic Cells Remarkably Enhances the Cancer Immunotherapy Effects of STING Agonist.
Journal: Nano letters
Published: November 15, 2021
Last Updated: 09/26/2026